Evidence map›Paper›PMID 23452388›Full record

ArticleBiomaterials2013

Effect of avidin-like proteins and biotin modification on mesenchymal stem cell adhesion.

Ray C Schmidt, Kevin E Healy

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ray C SchmidtDepartment of Bioengineering, University of California at Berkeley, Berkeley, CA, USA.
Kevin E Healy
University of California, Berkeley · US

Funding

Enabling Technologies for hES Cell Self-RenewalR01HL096525 · NHLBI · UNIVERSITY OF CALIFORNIA BERKELEY · PI HEALY, KEVIN EDWARD · 2009 to 2013
$1.8M
Nanopatterned Surfaces to Control Cell FateR01GM085754 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI HEALY, KEVIN EDWARD · 2009 to 2012
$1.4M
Nanopatterned Surfaces to Control Cell FateR21EB005812 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI HEALY, KEVIN EDWARD · 2005 to 2006
$378k
NHLBI NIH HHS R01 HL096525NIBIB NIH HHS EB-0058121NIBIB NIH HHS R21 EB005812NIGMS NIH HHS GM085754NIGMS NIH HHS R01 GM085754
6 · The paper itself

Abstract

The avidin-biotin system is a highly specific reaction that has been used in a wide range of biomedical applications, including surface modification and cell patterning. We systematically examined a number of avidin derivatives as the basis for a simple and cost effective tissue culture polystyrene substrate surface modification for human stem cell culture. Non-specific adhesion between human mesenchymal stem cells and various avidin derivatives, media conditions, and subsequent biotinylation reactions was quantified. We observed significant non-specific cell adhesion to avidin and strepthavidin, indicating that previous observations using this system may be artifactual. Seeding of cells in serum free media, blocking with bovine serum albumin, and the use of the avidin derivative neutravidin were all necessary for elimination of background adhesion. Neutravidin conjugated with biotinylated bsp-RGD(15) peptide provided the most robust cell adhesion, as well as the greatest increase in cell adhesion over background levels.

Indexed as

Amino Acid SequenceAnimalsAvidinBiotinCattleCell AdhesionCulture Media, Serum-FreeHot TemperatureHumansMesenchymal Stem CellsMolecular Sequence DataPeptidesSerum Albumin, BovineAvidinBiotinCulture Media, Serum-FreePeptidesSerum Albumin, Bovine

Identifiers

PMID23452388
PMCPMC3900499
OpenAlexW2053679756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.